Diabetes
High-phenol olive oil shifts inflammatory gene programs in MetS
Open access · cc by · source: Europe PMC
In 20 MetS patients, a randomized crossover of high-phenol (398 ppm) vs low-phenol (70 ppm) virgin olive oil breakfasts changed 98 PBMC genes postprandially, including inflammation-linked transcripts.
Study at a glance
- Design
- RCT — Double-blind randomized crossover of high- vs low-phenol virgin olive oil breakfasts
- N
- N=20 · Metabolic-syndrome patients; 398 vs 70 ppm phenol content
- Population
- Adults with metabolic syndrome
- Outcome
- Postprandial PBMC gene-expression differences (high vs low phenol)
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
High- vs low-phenol olive oil yielded 98 differentially expressed genes (79 down, 19 up). Many mapped to obesity/dyslipidemia/type 2 diabetes pathways, including inflammatory programs involving NF-κB, AP-1, cytokines, MAPKs, and arachidonic-acid related processes. Authors conclude the phenol fraction can repress inflammation-related gene expression in vivo during the postprandial period.
Methodology
Twenty metabolic-syndrome patients completed a double-blind, randomized, crossover comparison of virgin olive oil breakfasts differing mainly in phenolic content (398 vs 70 ppm) while on a shared low-fat, carbohydrate-rich background diet. Authors ran postprandial PBMC microarray gene-expression analysis.
Limitations
Acute postprandial transcript changes are not proof of long-term MetS remission. n=20 limits precision. Olive oil meals are not a substitute for medications when indicated.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Higher MetS severity tracks faster epigenetic aging; year-20 IEAA predicts later incident MetS.
In CARDIA, MetS severity associated with intrinsic epigenetic age acceleration, and year-20 IEAA predicted year-30 incident MetS (OR 1.05 per unit) — a longitudinal methylation-age link, not a completed anti-aging MetS trial.
Scope note — acute postprandial transcript shifts after phenol-rich oil, not multi-year epigenetic clocks
Limits the claim's scope: a different population, assay, or outcome.
High-phenol virgin olive oil acutely changes inflammatory gene programs in MetS PBMCs.
In a 20-patient randomized crossover, high- vs low-phenol olive oil breakfasts altered 98 PBMC genes postprandially, including inflammation-linked transcripts — an acute meal effect, not long-term MetS remission.
Evidence for the claim as stated.
Microbiome correlates, methylation-age risk, acute dietary transcript shifts, and SNP heritability all sit under MetS without sharing one assay or one intervention claim.
Evidence for the claim as stated.
A modest OR linking IEAA to incident MetS is a different clinical claim from an acute 98-gene olive-oil meal effect — both can be true without interchangeable advice.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Microbiome correlates, methylation-age risk, acute dietary transcript shifts, and SNP heritability all sit under MetS without sharing one assay or one intervention claim.
A modest OR linking IEAA to incident MetS is a different clinical claim from an acute 98-gene olive-oil meal effect — both can be true without interchangeable advice.
Related papers in this topic
Same topic cluster — not a recommendation engine.